NEXUS AG (NXU.DE) Stock Price, Quote, News and Overview
FRA:NXU - Deutsche Boerse Ag - DE0005220909 - Common Stock - Currency: EUR
NXU.DE Quote, Performance and Key Statistics
NEXUS AG
FRA:NXU (2/4/2025, 7:00:00 PM)
68.6
-0.1 (-0.15%)
The current stock price of NXU.DE is 68.6 EUR. In the past month the price increased by 0.29%. In the past year, price increased by 13.01%.
NXU.DE Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEE.DE | VEEVA SYSTEMS INC-CLASS A | 37.14 | 36.66B | ||
| COP.DE | COMPUGROUP MEDICAL SE & CO K | 47.58 | 1.23B | ||
| EQS.PA | EQUASENS | 11.81 | 555.22M | ||
| CONTX.OL | CONTEXTVISION AB | 18.14 | 393.04M | ||
| GPI.MI | GPI SPA | 3 | 276.67M | ||
| CGM.PA | CEGEDIM SA | 80 | 169.20M | ||
| AGFB.BR | AGFA-GEVAERT NV | N/A | 138.25M | ||
| ALMDT.PA | MEDIAN TECHNOLOGIES | N/A | 61.94M | ||
| M3V.DE | MEVIS MEDICAL SOLUTIONS AG | N/A | 46.96M | ||
| AJ91.DE | DOCCHECK AG | 18.65 | 45.38M | ||
| ALINS.PA | INTRASENSE SAS | N/A | 14.21M |
Related stock screener links
About NXU.DE
Company Profile
NEXUS AG engages in the development and sale of software and hardware solutions. The company is headquartered in Donaueschingen, Baden-Wuerttemberg and currently employs 1,853 full-time employees. The company went IPO on 2000-07-24. The firm is engaged in the development, trade and service of software solutions for facilities of the healthcare system. The company is divided into three divisions: NEXUS/ DE (Germany), NEXUS/ DIS (Diagnostic systems) and NEXUS/ ROE (Rest of Europe). The firm has different product groups such as: NEXUS/ HISng, an information system for somatic hospitals in Germany; NEXUS/ PSYCHIATRY, an information system for psychiatric institutions; NEXUS/ REHAng, an information system for rehabilitation facilities; NEXUS/ ITR, a software for rehabilitation, private, acute care clinics not providing surgery and hotels with medical care; NEXUS/ ARCHIVE and NEXUS/ PEGASOS, provides archiving and process management in healthcare, among others.
Company Info
NEXUS AG
Irmastrasse 1
Donaueschingen BADEN-WUERTTEMBERG DE
Employees: 1853
Company Website: https://www.nexus-ag.de/
Investor Relations: http://www.nexus-ehealth.com/company/investor-relations
Phone: 49771229600
NXU.DE FAQ
What is the stock price of NXU.DE?
The current stock price of NXU.DE is 68.6 EUR.
What is the symbol for NEXUS AG stock?
The exchange symbol of NEXUS AG is NXU and it is listed on the Deutsche Boerse Ag exchange.
On which exchange is NXU.DE stock listed?
NXU.DE stock is listed on the Deutsche Boerse Ag exchange.
Is NXU.DE a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for NXU.DE, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of NXU.DE.
Does NXU.DE stock pay dividends?
NXU.DE has a dividend yield of 0.32%. The yearly dividend amount is currently 0.21.
What is the Price/Earnings (PE) ratio of NXU.DE?
The PE ratio for NXU.DE is 44.26. This is based on the reported non-GAAP earnings per share of 1.55 and the current share price of 68.6 EUR.
NXU.DE Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to NXU.DE. When comparing the yearly performance of all stocks, NXU.DE turns out to be only a medium performer in the overall market: it outperformed 50.83% of all stocks.
NXU.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to NXU.DE. NXU.DE has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
NXU.DE Financial Highlights
Over the last trailing twelve months NXU.DE reported a non-GAAP Earnings per Share(EPS) of 1.55. The EPS increased by 12.99% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 10.25% | ||
| ROA | 6.44% | ||
| ROE | 10.07% | ||
| Debt/Equity | 0.06 |
NXU.DE Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 69% to NXU.DE. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of 8.29% and a revenue growth 14.41% for NXU.DE